AK-114
- Generic Name
- AK-114
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK114
- First Posted Date
- 2022-01-20
- Last Posted Date
- 2022-01-20
- Lead Sponsor
- Akeso
- Target Recruit Count
- 30
- Registration Number
- NCT05200273
- Locations
- 🇦🇺
Ashford Cancer Centre, Kurralta Park, South Australia, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath